Stephen Taub Could Merck Become an Activist Target? One Hedge Fund Thinks So Suvretta Capital Management — which is not an activist investor — lays out the case in its second quarter letter. Stephen Taub September 21, 2018 (Daniel Acker/Bloomberg)